Priapism in hematological and coagulative disorders: An update

Nature Reviews Urology

Volumn 8, Issue 4, 2011, Pages 223-230

  Morrison, Belinda F ^a   Burnett, Arthur L ^b  

^a UNIVERSITY OF THE WEST INDIES   (Jamaica)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENALIN; ADRENERGIC RECEPTOR STIMULATING AGENT; ANALGESIC AGENT; ANTIANDROGEN; BACLOFEN; BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; BICALUTAMIDE; CYPROTERONE ACETATE; DIETHYLSTILBESTROL; DIGOXIN; EPHEDRINE; ETILEFRINE; FINASTERIDE; FLUTAMIDE; GONADORELIN AGONIST; HYDRALAZINE; HYDROXYUREA; KETOCONAZOLE; METARAMINOL; NARCOTIC AGENT; NILUTAMIDE; PHENYLEPHRINE; PHENYLETHANOLAMINE N METHYLTRANSFERASE; PHOSPHODIESTERASE INHIBITOR; PHOSPHODIESTERASE V INHIBITOR; PROCYCLIDINE; PSEUDOEPHEDRINE; SILDENAFIL; TERBUTALINE; UNINDEXED DRUG;

ARTERIOGRAPHY; BLOOD CELL COUNT; BLOOD CLOTTING DISORDER; BRADYCARDIA; CANCER SCREENING; CAVERNOSOGRAPHY; CONSERVATIVE TREATMENT; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; DISEASE COURSE; DOPPLER ECHOGRAPHY; DRUG EFFICACY; DRUG INDUCED HEADACHE; DRUG RESEARCH; ERECTILE DYSFUNCTION; EXCHANGE BLOOD TRANSFUSION; FLUID THERAPY; GLUCOSE 6 PHOSPHATE DEHYDROGENASE DEFICIENCY; HEART PALPITATION; HEMATOLOGIC DISEASE; HEMATOMA; HUMAN; HYPERTENSION; INJECTION SITE FIBROSIS; INJECTION SITE PAIN; ISCHEMIC PRIAPISM; LIGATION; MALE GENITAL SYSTEM SURGERY; MEDICAL HISTORY; NONHUMAN; NONISCHEMIC PRIAPISM; OXYGEN THERAPY; PATHOPHYSIOLOGY; PENIS ASPIRATION; PENIS ERECTION; PENIS PROSTHESIS; PENIS SHUNT; PHYSICAL EXAMINATION; PRIAPISM; PRIMAPISM; PRIORITY JOURNAL; PROSTATE CANCER; REVIEW; SCINTIGRAPHY; SICKLE CELL ANEMIA; STUTTERING PRIAPISM; TACHYCARDIA; UNSPECIFIED SIDE EFFECT; VEIN OCCLUSION; VEIN THROMBOSIS; VENOCONSTRICTION;

ANIMALS; BLOOD COAGULATION DISORDERS; HEMATOLOGIC DISEASES; HUMANS; MALE; PRIAPISM;

EID: 79954416437     PISSN: 17594812     EISSN: 17594820     Source Type: Journal    
DOI: 10.1038/nrurol.2011.28     Document Type: Review

References (79)

1. Montague, D. K. et al. American Urological Association guideline on the management of priapism. J. Urol. 170, 1318-1324 (2003). (Pubitemid 37108148)
2. Burnett, A. L. Pathophysiology of priapism: dysregulatory erection physiology thesis. J. Urol. 170, 26-34 (2003). (Pubitemid 36734404)
3. Eland I. A., van der Lei, J., Stricker, B. H. & Sturkenboom, M. J. Incidence of priapism in the general population. Urology 57 970-972 (2001). (Pubitemid 32405323)
4. Serjeant, G. R. Observations on the epidemiology of sickle cell disease. Trans. R. Soc Trop. Med. Hyg. 75, 228-233 (1981).
5. Emond, A. M., Holman, R., Hayes, R. J. & Serjeant, G. R. Priapism and impotence in homozygous sickle cell disease. Arch. Intern. Med. 140, 1434-1437 (1980). (Pubitemid 10024955)
6. rd & Winter, C C Priapism: evolution of management in 48 patients in a 22-year series. J. Urol. 117, 455-458 (1977). (Pubitemid 8093945)
7. Winter, C C Priapism. Urol. Surv. 28, 163-166 (1978).
8. Mantadakis, E., Cavender, J. D., Rogers, Z. R., Ewalt, D. H. & Buchanan, G. R. Prevalence of priapism in children and adolescents with sickle cell anemia. J. Pediatr. Hematol. Oncol. 21, 518-522 (1999). (Pubitemid 30305987)
9. Thuret, I. et al. Priapism following splenectomy in an unstable hemoglobin: hemoglobin Olmsted beta 141 (H19) Arg. Am. J. Hematol. 51, 133-136 (1996). (Pubitemid 26060002)
10. Miller, S. T., Rao, S. P, Dunn, E. K. & Glassberg, K. I. Priapism in children with sickle cell disease. J. Urol. 154, 844-847 (1995).
11. Tzortzis, V et al. Oral phosphodiesterase type 5 inhibitors alleviate recurrent priapism complicating thalassemia intermedia: a case report. J. Sex Med. 6, 2068-2071 (2009).
12. Ziaee, S. A. & Javaherforooshzadeh, A. Priapism in a 15-year-old boy with major beta-thalassemia. Urol. J. 5, 55-56 (2008).
13. Fowler, J. E. Jr, Koshy, M., Strub, M. & Chinn, S. K. Priapism associated with the sickle cel hemoglobinopathies: prevalence, natural history and sequelae. J. Urol. 145, 65-68 (1991).
14. Burnett, A. L. & Bivalacqua, T. J. Glucose-6-phosphate dehydrogenase deficiency: an etiology for idiopathic priapism? J. Sex Med. 5, 237-240 (2008).
15. Finley, D. S. Glucose-6-phosphate dehydrogenase deficiency associated stuttering priapism: report of a case. J. Sex Med. 5, 2963-2966 (2008).
16. Ponniah, A., Brown, C T. & Taylor, P Priapism secondary to leukemia: effective management with prompt leukapheresis. Int. J. Urol. 11, 809-810 (2004). (Pubitemid 39387536)
17. Schreibman, S. M., Gee, T. S. & Grabstald, H. Management of priapism in patients with chronic granulocytic leukemia. J. Urol. 111, 786-788 (1974).
18. Allue Lopez, M. et al. Priapism as an initial presentation of chronic myeloid leukaemia [Spanish]. Actas Urol. Esp. 28, 387-389 (2004).
19. Rosenbaum, E. H., Thompson, H. E. & Glassberg, A. B. Priapism and multiple myeloma. Successful treatment with plasmapheresis. Urology 12, 201-202 (1978). (Pubitemid 8404908)
20. Madeb, R., Rub, R., Erlich, N., Hegarty, P K. & Yachia, D. Long standing priapism as presentation of lymphoma. Am. J. Hematol. 82, 87 (2007). (Pubitemid 46033404)
21. Krco, M. J., Jacobs, S. C & Lawson, R. K. Priapism due to solid malignancy. Urology 23, 264-266 (1984). (Pubitemid 14164875)
22. Chan, P T. et al. Priapism secondary to penile metastasis: a report of two cases and a review of the literature. J. Surg. Oncol. 68, 51-59 (1998). (Pubitemid 28243869)
23. Kwok, B. & Varol, C Priapism and penile gangrene due to thrombotic thrombocytopenic purpura. Urology 75, 71-72 (2010).
24. Edney, M. T., Schned, A. R., Cendron, M., Chaffee, S. & Ellsworth, P I. Priapism in a 15-year-old boy with congenital dyserythropoietic anemia type II (hereditary erythroblastic multinuclearity with positive acidified serum lysis test). J. Urol. 167, 309-310 (2002). (Pubitemid 34024576)
25. Sari, I. et al. Thrombosis and priapism in a patient with Henoch-Schonlein purpura. Rheumatol. Int 25, 472-474 (2005). (Pubitemid 41186919)
26. Prabhakaran, K., Jacobs, B. L., Smaldone, M. C & Franks, M. E. Stuttering priapism associated with hereditary spherocytosis. Can. J. Urol. 14, 3702-3704 (2007).
27. Muñoz Vélez, D., Rebassa Llull, M., Conte Visús, A. & Ozonas Moragues, M. Low-flow priapism associated with systemic lupus erythematosus and nephrotic syndrome [Spanish]. Arch. Esp. Urol. 53, 929-930 (2000).
28. Walker, J. R. & Casale, A. J. Prolonged penile erection in the newborn. Urology 50, 796-799 (1997). (Pubitemid 27495009)
29. Daryanani, S. & Wilde, J. T. Priapism in a patient with protein C deficiency. Clin. Lab. Haematol. 19, 213-214 (1997). (Pubitemid 27431476)
30. Rehman, J. U., Kindi, S. S., Pathare, A. V., Jain, R. & Choudry, A. Recurrent priapism in sickle cell trait with protein S deficiency. J. Pak. Med. Assoc 58, 701-702 (2008).
31. Gyan, E. et al. Acute priapism in a patient with unstable hemoglobin Perth and Factor V Leiden under effective oral anticoagulant therapy Hematol. J. 2, 210-211 (2001). (Pubitemid 32633674)
32. Moalla, M., Gabsi, M., el Ouakdi, M., Zmerli, S. & Ben Ayed, H. Behçet disease and priapism. J. Rheumatol. 17, 570-571 (1990).
33. Routledge, P A., Shetty, H. G., White, J. P & Collins, P Case studies in therapeutics: warfarin resistance and inefficacy in a man with recurrent thromboembolism, and anticoagulant-associated priapism. Br. J. Clin. Pharmacol. 46, 343-346 (1998).
34. Klein, E. A., Montague, D. K. & Steiger, E. Priapism associated with the use of intravenous fat emulsion: case reports and postulated pathogenesis. J. Urol. 133, 857-859 (1985). (Pubitemid 15036427)
35. Atala, A., Amin, M., Harty, J. I., Liu, Y K. & Keeling, M. M. Priapism associated with asplenic state. Urology 40, 371-373 (1992).
36. Lapan, D. I., Graham, A. R., Bangert, J. L., Boyer, J. T. & Conner, W. T. Amyloidosis presenting as priapism. Urology 15, 167-170 (1980).
37. Goulding, F. J. Priapism caused by glucose phosphate isomerase deficiency. J. Urol. 116, 819-820 (1976). (Pubitemid 8008665)
38. Ramos, C E., Park, J. S., Ritchey, M. L. & Benson, G. S. High flow priapism associated with sickle cell disease. J. Urol. 153, 1619-1621 (1995).
39. Burt, F. B., Schirmer, H. K. & Scott, W. W. A new concept in the management of priapism. J. Urol. 83, 60-61 (1960).
40. Foda, M. M. et al. High-flow priapism associated with Fabry's disease in a child: a case report and review of the literature. Urology 48, 949-952 (1996). (Pubitemid 26427110)
41. Kulmala, R., Lehtonen, T., Nieminen, P & Tammela, T. Aetiology of priapism in 207 patients. Eur. Urol. 28, 241-245 (1995).
42. Pryor, J. et al. Priapism. J. Sex Med. 1, 116-120 (2004). (Pubitemid 40424675)
43. El-Bahnasawy, M. S., Dawood, A. & Farouk, A. Low-flow priapism: risk factors for erectile dysfunction. BJU Int 89, 285-290 (2002). (Pubitemid 34158463)
44. Adeyoju, A. B. et al. Priapism in sickle-cell disease; incidence, risk factors and complications-an international multicentre study. BJU Int. 90, 898-902 (2002). (Pubitemid 36693626)
45. Datta, N. S. Megalophallus in sickle cel disease. J. Urol. 117, 672-673 (1977).
46. Hinman, F. Priapism: report of cases and a clinical study of the literature with reference to its pathogenesis and surgical treatment. Ann. Surg. 60, 689-716 (1914).
47. Hinman, F. Jr. Priapism; reasons for failure of therapy. J. Urol. 83, 420-428 (1960).
48. Yuan, J., Desouza, R., Westney, O. L. & Wang, R. Insights of priapism mechanism and rationale treatment for recurrent priapism. Asian J. Androl. 10, 88-101 (2008).
49. Champion, H. C., Bivalacqua, T. J., Takimoto, E., Kass, D. A. & Burnett, A. L. Phosphodiesterase-5A dysregulation in penile erectile tissue is a mechanism of priapism. Proc. Natl Acad. Sci. USA 102, 1661-1666 (2005). (Pubitemid 40209224)
50. Bivalacqua, T. J., Liu, T., Musicki, B., Champion, H. C & Burnett, A. L. Endothelial nitric oxide synthase keeps erection regulatory function balance in the penis. Eur. Urol. 51, 1732-1740 (2007). (Pubitemid 46634738)
51. 2B adenosine receptor signaling. J. Clin. Invest 118, 1491-1501 (2008). (Pubitemid 351500442)
52. Kanika, N. D. et al. The mechanism of opiorphin-induced experimental priapism in rats involves activation of the polyamine synthetic pathway Am. J. Physiol. Cell Physiol. 297, C916-C927 (2009).
53. Spycher, M. A. & Hauri, D. The ultrastructure of the erectile tissue in priapism. J. Urol. 135, 142-147 (1986).
54. Lee, M., Cannon, B. & Sharifi, R. Chart for preparation of dilutions of alpha-adrenergic agonists for intracavernous use in treatment of priapism. J. Urol. 153, 1182-1183 (1995).
55. Winter, C C Priapism cured by creation of fistulas between glans penis and corpora cavernosa. J. Urol. 119; 227-228 (1978). (Pubitemid 8297130)
56. Ercole, C J., Pontes, J. E. & Pierce, J. M. Jr. Changing surgical concepts in the treatment of priapism. J. Urol. 125, 210-211 (1981). (Pubitemid 11139619)
57. Ebbehoj, J. A new operation for priapism. Scand. J. Plast Reconstr. Surg. 8, 241-242 (1974).
58. Garcia, M. M., Shindel, A. W. & Lue, T F T-shunt with or without tunnelling for prolonged ischaemic priapism. BJU Int 102, 1754-1764 (2008).
59. Burnett, A. L. & Pierorazio, P M. Corporal "snake" maneuver: corporoglanular shunt surgical modification for ischemic priapism. J. Sex Med. 6, 1171-1176 (2009).
60. Rees, R. W. et al. The management of Low-flow priapism with the immediate insertion of a penile prosthesis. BJU Int 90, 893-897 (2002). (Pubitemid 36693625)
61. Ralph, D. J. et al. The immediate insertion of a penile prosthesis for acute ischaemic priapism. Eur. Urol. 56, 1033-1038 (2009).
62. Durazi, M. H. & Jalal, A. A. Penile prosthesis mplantation for treatment of postpriapism erectile dysfunction. Urol. J. 5, 115-119 (2008).
63. Tazi, I. Priapism as the first manifestation of chronic myeloid leukemia. Ann. Saudi Med. 29, 412 (2009).
64. Burnett, A. L., Bivalacqua, T J., Champion, H. C & Musicki, B. Feasibility of the use of phosphodiesterase type 5 inhibitors in a pharmacologic prevention program for recurrent priapism. J. Sex Med. 3, 1077-1084 (2006). (Pubitemid 44644720)
65. Ahmed, I. & Shaikh, N. A. Treatment of intermittent idiopathic priapism with oral terbutaline. Br. J. Urol. 80, 341 (1997). (Pubitemid 28318910)
66. Virag, R., Bachir, D., Lee, K. & Galacteros, F Preventive treatment of priapism in sickle cell disease with oral and self-administered intracavernous injection of etilefrine. Urology 47, 777-781 (1996). (Pubitemid 26172756)
67. Muneer, A., Minhas, S., Arya, M. & Ralph, D. J. Stuttering priapism\a review of the therapeutic options. Int. J. Clin. Pract 62, 1265-1270 (2008). (Pubitemid 351977612)
68. Olujohungbe, A. B. et al. A prospective diary study of stuttering priapism in adolescents and young men with sickle cell anemia: report of an international randomized control trial; The Priapism In Sickle Cell Study (PISCES study). J. Androl. doi:10.2164/jandrol.110.010934.
69. Levine, L. A. & Guss, S. P Gonadotropin-releasing hormone analogues in the treatment of sickle cel anemia-associated priapism. J. Urol. 150, 475-477 (1993). (Pubitemid 23215901)
70. Dahm, P, Rao, D. S. & Donatucci, C F Antiandrogens in the treatment of priapism. Urology 59, 138 (2002).
71. Serjeant, G. R., de Ceulaer, K. & Maude, G. H. Stilboestrol and stuttering priapism in homozygous sickle-cell disease. Lancet 2, 1274-1276 (1985). (Pubitemid 16192719)
72. Rachid-Filho, D., Cavalcanti, A. G., Favorito, L A., Costa, W. S. & Sampaio, F J. Treatment of recurrent priapism in sickle cell anemia with finasteride: a new approach. Urology 74, 1054-1057 (2009).
73. Burnett, A. L., Bivalacqua, T J., Champion, H. C & Musicki, B. Long-term oral phosphodiesterase 5 inhibitor therapy alleviates recurrent priapism. Urology 67, 1043-1048 (2006). (Pubitemid 43956437)
74. Gupta, S. et al. A possible mechanism for alteration of human erectile function by digoxin: inhibition of corpus cavernosum sodium/potassium adenosine triphosphatase activity J. Urol. 159, 1529-1536 (1998). (Pubitemid 29117335)
75. Perimenis, P, Athanasopoulos, A., Papathanasopoulos, P & Barbalias, G. Gabapentin in the management of the recurrent, refractory, idiopathic priapism. Int J. Impot Res. 16, 84-85 (2004). (Pubitemid 38401566)
76. Rourke, K. F., Fischler, A. H. & Jordan, G. H. Treatment of recurrent idiopathic priapism with oral baclofen. J. Urol. 168, 2552; discussion 2552-2553 (2002). (Pubitemid 35402675)
77. Baruchel, S., Rees, J., Bernstein, M. L. & Goodyer, P Relief of sickle cell priapism by hydralazine. Report of a case. Am. J. Pediatr. Hematol. Oncol. 15, 115-116 (1993). (Pubitemid 23061721)
78. Saad, S. T et al. Follow-up of sickle cell disease patients with priapism treated by hydroxyurea. Am. J. Hematol. 77, 45-49 (2004). (Pubitemid 39108796)
79. Wen, J. et al. Adenosine deaminase enzyme therapy prevents and reverses the heightened cavernosal relaxation in priapism. J. Sex Med. 7, 3011-3022 (2010).